
U.S. stocks were lower, with the Dow Jones index falling over 100 points on Monday.
Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) rose sharply during Monday's session after the company announced it won FDA approval for EKTERLY.

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Monday.
Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) rose sharply during Monday's session after the company announced it won FDA approval for EKTERLY.